Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm

Biomedicine and Pharmacotherapy

Volumn 61, Issue 5, 2007, Pages 268-271

  Armani, Chiara ^a   Curcio, Michele ^a   Barsotti, Maria Chiara ^a   Santoni, Tatiana ^a   Di Stefano, Rossella ^a   Dell'Omodarme, Matteo ^a   Brandi, Maria Luisa ^a   Ferrari, Mauro ^a   Scatena, Fabrizio ^a   Carpi, Angelo ^a   Balbarini, Alberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Aneurysm; Metalloproteinases; Polymorphism

Indexed keywords

GELATINASE B; SCLEROPROTEIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 34249998371     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.12.002     Document Type: Article

References (29)

1. Verloes A., Sakalihasan N., Koulischer L., and Limet R. Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 2 (1995) 646-655
2. Tilson M.D., and Seashore M.R. Human genetics of the abdominal aortic aneurysm. Surg Gynecol Obstet 158 (1984) 129-132
3. Kadoglou N.P., and Liapis C.D. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 20 (2004) 419-432
4. Treharne G.D., Boyle J.R., Goodall S., Loftus I.M., Bell P.R., and Thompson M.M. Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease. Br J Surg 86 (1999) 1053-1058
5. Thompson R.W., Holmes D.R., Mertens R.A., Liao S., Botney M.D., Mecham R.P., et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 96 (1995) 318-326
6. Mao D., VanVickle S.J., Curci J.A., and Thompson R.W. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 13 (1999) 236-237
7. Vine N., and Powell J.T. Metalloproteinases in degenerative aortic disease. Clin Sci (Lond) 81 (1991) 233-239
8. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., and Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15 (1995) 1145-1151
9. Annabi B., Shedid D., Ghosn P., Kenigsberg R.L., Desrosiers R.R., Bojanowski M.W., et al. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J Vasc Surg 35 (2002) 539-546
10. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6 (1990) 121-125
11. Yamashita A., Noma T., Nakazawa A., Saito S., Fujioka K., Zempo N., et al. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms. World J Surg 25 (2001) 259-265
12. Saito S., Zempo N., Yamashita A., Takenaka H., Fujioka K., and Esato K. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease. Vasc Endovascular Surg 36 (2002) 1-7
13. Lindholt J.S., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study Eur J Vasc Endovasc Surg 20 (2000) 281-285
14. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
15. Petersen E., Gineitis A., Wagberg F., and Angquist K.A. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture. Eur J Vasc Endovasc Surg 20 (2000) 457-461
16. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 315 (1996) 335-342
17. Kondapaka S.B., Fridman R., and Reddy K.B. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer 70 (1997) 722-726
18. Jones G.T., Phillips V.L., Harris E.L., Rossaak J.I., and Van Rij A.M. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 8 (2003) 1363-1367
19. Ogata T., Shibamura H., Tromp G., Sinha M., Goddard K.A., Sakalihasan N., et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 41 (2005) 1036-1042
20. Yoon S., Tromp G., Vongpunsawad S., Ronkainen A., Juvonen T., and Kuivaniemi H. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265 (1999) 563-568
21. Zhang B., Ye S., Herrmann S.M., Eriksson P., De Maat M., Evans A., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
22. St Jean P.L., Zhang X.C., Hart B.K., Lamlum H., Webster M.W., Steed D.L., et al. Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease. Ann Hum Genet 59 (1995) 17-24
23. Shimajiri S., Arima N., Tanimoto A., Murata Y., Hamada T., Wang K.Y., et al. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett 455 (1999) 70-74
24. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
25. R Development Core Team. R: A language and environment for statistical computing (2005), R Foundation for Statistical Computing, Vienna, Austria
26. Armitage P., Berry G., and Matthews J.N.S. Statistical methods in medical research (2002), Blackwell Publishing, Oxford, UK
27. Montaner J., Fernandez-Cadenas I., Molina C.A., Monasterio J., Arenillas J.F., Ribo M., et al. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Stroke 34 (2003) 2851-2855
28. Zhang B., Dhillon S., Geary I., Howell W.M., Iannotti F., Day I.N., et al. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 32 (2001) 2198-2202
29. Lamblin N., Bauters C., Hermant X., Lablanche J.M., Helbecque N., and Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 40 (2002) 43-48